Provided by Tiger Trade Technology Pte. Ltd.

Cellebrite

14.54
-0.0450-0.31%
Volume:33.68K
Turnover:487.72K
Market Cap:3.63B
PE:46.89
High:14.57
Open:14.42
Low:14.42
Close:14.58
52wk High:20.86
52wk Low:11.76
Shares:249.44M
Float Shares:112.43M
Volume Ratio:1.66
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3100
EPS(LYR):0.3100
ROE:19.10%
ROA:5.10%
PB:7.49
PE(LYR):46.89

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

Could Cellebrite (CLBT) Strengthen Its Regulatory Edge With New Legal Leadership Amid AI Transitions?

Simply Wall St.
·
Nov 12, 2025

Cellebrite (CLBT): Assessing Valuation Potential After Recent Stock Volatility

Simply Wall St.
·
Nov 11, 2025

Cellebrite Names Holly Windham as General Counsel and Chief Compliance Officer

Reuters
·
Oct 30, 2025

Terry Crews to Headline Cellebrite C2C User Summit

Reuters
·
Oct 28, 2025

Cellebrite (CLBT): Evaluating Valuation as Cloud Growth and FedRAMP Potential Draw Investor Focus

Simply Wall St.
·
Oct 27, 2025

Cellebrite to Report Third-Quarter 2025 Financial Results on November 12, 2025

GlobeNewswire
·
Oct 17, 2025

Cellebrite DI (CLBT) Receives a Buy from TD Cowen

TIPRANKS
·
Oct 17, 2025

Analysts Are Bullish on Top Technology Stocks: Cellebrite DI (CLBT), PDF Solutions (PDFS)

TIPRANKS
·
Oct 16, 2025

Cellebrite Expands Market Reach with Innovations in Agentic AI, Cloud and Device Virtualization for the Company’s Autumn 2025 Release

GlobeNewswire
·
Oct 15, 2025

Cellebrite DI (NasdaqGS:CLBT) Valuation in Focus as Institutional Interest Rises After Notable Investments

Simply Wall St.
·
Oct 11, 2025

ValueAct Capital’s Stake in Sun Corp Might Change The Case For Investing In Cellebrite DI (CLBT)

Simply Wall St.
·
Oct 10, 2025

Cellebrite DI (CLBT) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Oct 09, 2025

Cellebrite DI (CLBT) Receives a Buy from Lake Street

TIPRANKS
·
Oct 09, 2025

Press Release: ValueAct Capital Files Large Shareholder Report in Sun Corp

Dow Jones
·
Oct 09, 2025

Cellebrite DI Is Maintained at Overweight by JP Morgan

Dow Jones
·
Sep 24, 2025

Cellebrite DI Ltd : JP Morgan Raises Target Price to $23 From $20

THOMSON REUTERS
·
Sep 24, 2025

Cellebrite Shareholders Approve Proposals in Annual General Meeting with 76.82% Voting Participation

Reuters
·
Sep 23, 2025